Navigation Links
Novavax Announces Closing of $18 Million Registered Direct Offering
Date:8/1/2008

apital and other costs Novavax will incur to exit the manufacturing facility; our ability to enter into future collaborations with industry partners and the terms, timing and success of any such collaboration; the cost of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; our ability to obtain rights to technology; competition for clinical resources and patient enrollment from drug candidates in development by other companies with greater resources and visibility; our ability to obtain adequate financing in the future through product licensing, co-promotional arrangements, public or private equity or debt financing or otherwise; general business conditions; competition; business abilities and judgment of personnel; and the availability of qualified personnel. Further information on the factors and risks that could affect Novavax's business, financial conditions and results of operations, is contained in Novavax's filings with the SEC, which are available at http://www.sec.gov. These forward-looking statements speak only as of the date of this press release, and Novavax assumes no duty to update forward-looking statements.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. Novavax Reports First Quarter 2008 Financial Results
8. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
9. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
10. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
11. Novavax to Join Russell 3000 Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., IRVINE, Calif., Dec. 4 /PRNewswire-FirstCall/ ...d: BFRE), a company focused on changing the world,...ion of ethanol from non-food cellulosic wastes, ha...ist of the "50 Hottest Companies in Bioenergy;" th... ,, "Having voters rank BlueFire Ethanol among...
(Date:12/3/2009)..., SAN FRANCISCO, Dec. 3 ...technology company focused on the development of c...etabolic disease, today announced that it has comp...T clinical trial of VIA-2291. ,, The FDG-PET t...ive sites in the US and Canada including Massachus...
(Date:12/3/2009)..., HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstCall... a leading provider of tools and services for drug...duced Living Image 4.0 software for IVIS® in ... the more than 800 Caliper IVIS systems currently ...4.0 features advanced spectral unmixing tools to e...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlin...t is available in its catalogue: ,, Neurostimu...//www.reportlinker.com/p0164232/Neurostimulation--...d neurostimulation market stands enthused by the g... rise in age-related diseases such as, Parkinson,s...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
...s,Pharmaceuticals, Inc. (Nasdaq: IDEV ) today an... the fiscal year and the three-month period ended ...rence call and webcast today beginning,at 9:00 am ...ompany reported fiscal 2008 consolidated revenues ...07 revenues of $66.1 million. For the three-,mont...
... Heart, Inc. is pleased to,announce the appointmen...ive,Officer (C.E.O.) and President, effective imme...Terumo Heart is positioned for a strong leadership...am excited to lead the acceleration,of enrollment ...linical sites,and further capitalize on the commer...
...c Imaging will produce its,11th Annual Webcast Fro...Radiology Society of North America Scientific Asse...L, from November 30th through December 5th. This,...ents taking place and will,be available on Diagnos...s the opportunity to join our team of editors as,t...
Other Biology Technology:Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 2Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 3Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 4Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 5Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 6Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 7Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 8Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 9Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 10Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 11Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President 2Diagnostic Imaging to Deliver Its 11th Annual Webcast of Key Events Taking Place at RSNA 2008 2
(Date:12/3/2009)...panish researchers have measured CO2 levels for th...phere) over a sparsely inhabited rural area near V...ir kind in the Iberian Peninsula, show that the le..., Over recent years, physicists and meteorologist...e (CO2) levels, and how these have evolved in the ...
(Date:12/3/2009)... 30-year record low in Antarctic snowmelt that occ... due to concurrent strong positive phases for two ...llation) and SAM (Southern Hemisphere Annular Mode...ssor of Earth & Atmospheric Sciences at The City C...s also on the doctoral faculty at the CUNY Graduat...
(Date:12/2/2009)...HILADELPHIA New study results strengthen the evid...period of time have an increased risk for developi...er risk factors. , "This provides one more reas...said senior author Michael J. Thun, M.D., M.S., vi...ce research at the American Cancer Society. "Color...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2EntreMed Reports Second Quarter 2009 Financial Results 53818 1EntreMed Reports Second Quarter 2009 Financial Results 53818 2EntreMed Reports Second Quarter 2009 Financial Results 53818 3EntreMed Reports Second Quarter 2009 Financial Results 53818 4Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 1Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 2Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 3Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 4Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 5Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 6Repligen Reports First Quarter Fiscal Year 2010 Financial Results 13408 7Celiac Disease Provides Clues To Solving Autoimmunity 53814 1Celiac Disease Provides Clues To Solving Autoimmunity 53814 2Celiac Disease Provides Clues To Solving Autoimmunity 53814 3
...y of Illinois study have demonstrated an effective...ate bars. , Eating two CocoaVia dark chocolate ba...unexpected effect of also lowering systolic blood ...f food science and human nutrition. , The study, ...s the bars, was published in this months Journal o...
...eview, scientists at Childrens Hospital & Research...ological or behavioral evidence linking vitamin D ...Ph.D., assistant staff scientist and Bruce N. Ames...kland Research Institute (CHORI) conclude that the...rtant role for vitamin D in brain development and ...
...e Multiplier for Shelbyville Police Department, W...TC Bulletin Board: BKYI), a leader in finger-based...ty solutions, today announced the,award of a contr...epartment") for the Department,s first mobile data...ireless messaging and query solution,officers on t...
Other Biology News:Chocolate bar shown to lower cholesterol 2Vitamin D in brain function 2Vitamin D in brain function 3BIO-key(R) Receives New Mobile Data Contract Award From Indiana Police Agency 2BIO-key(R) Receives New Mobile Data Contract Award From Indiana Police Agency 3
...dard is a new tuning and calibration standard for ...ctrometry. Accumix is a lyophilized 7-peptide sta...both tuning and calibration of ion trap (i.e. Finn...pectrometers. Direct infusion of the Accumix pept...
PIP Array from Echelon Biosciences Inc.
...ference Series 2000 Pipette is a synonym for pipet...st design, and superior operating comfort. Its sin... measuring stroke and blow-out as well as eject th...stem ensures utmost accuracy and precision. Ejecti...
Goat Anti-Human STMN2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: